Quarterly report pursuant to Section 13 or 15(d)

Debt and Interest - Additional Information (Detail)

v2.4.0.8
Debt and Interest - Additional Information (Detail) (USD $)
3 Months Ended 6 Months Ended 12 Months Ended 84 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Dec. 31, 2012
Installment
Jun. 30, 2013
Debt Instrument [Line Items]            
Accretion of obligation $ 485,000 $ 19,000 $ 961,000 $ 38,000   $ 4,914,000
Cash interest paid 351,000   698,000      
Current portion of note payable 4,611,000   4,611,000   1,799,000 4,611,000
Non Current portion of notes payable 9,760,000   9,760,000   12,386,000 9,760,000
Payment to acquire manufacturing rights         1,500,000  
Number of manufacturing rights installments         3  
Net present value of long term liabilities         1,000,000  
Interest rate on net present value         12.33%  
Carrying amount obligation         1,500,000  
Hercules Note [Member]
           
Debt Instrument [Line Items]            
Accretion of obligation 485,000   961,000      
Term loan with Hercules Technology Growth Capital 15,000,000   15,000,000     15,000,000
Interest expenses accretion of debt discounts 95,000   186,000      
Current portion of note payable 4,600,000   4,600,000     4,600,000
Non Current portion of notes payable 9,800,000   9,800,000     9,800,000
Debt discount recorded 629,000   629,000     629,000
Ovamed Manufacturing Rights [Member]
           
Debt Instrument [Line Items]            
Accretion of obligation 33,500   66,000      
Installment for manufacturing rights         $ 500,000